GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

0.000p
   
  • Closing Price Chg:
      23.00p
  • 52 Week High: 1,901.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,075.43m
  • Volume: 0
  • RiskGrade: 129
  • Beta: 0.94

Latest Deals

Traded Action Notifier PriceAmountValue
08-Jan-26 Buy Dividends Luke Miels 1,894.33p 3 £56.83
22-Dec-25 Buy Jonathan Symonds 1,810.46p 1,650 £29,872.59
19-Dec-25 Buy Vishal Sikka 3,629.58p 730 £26,495.90
19-Dec-25 Buy Jeannie Lee 3,629.58p 202 £7,331.74
19-Dec-25 Buy Anne Beal 3,629.58p 201 £7,295.45

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
19-Dec-25 Buy Charles Bancroft 3,629.20p 1,577 £57,232.50
22-Dec-25 Buy Jonathan Symonds 1,810.46p 1,650 £29,872.59
19-Dec-25 Buy Vishal Sikka 3,629.58p 730 £26,495.90
19-Dec-25 Buy Jeannie Lee 3,629.58p 202 £7,331.74
19-Dec-25 Buy Elizabeth (Liz) McKee Anderson 3,629.58p 201 £7,295.45

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,476,956 £0
Hal Barron 15,315,675 £0
Jonathan Symonds 71,193 £0
Charles Bancroft 67,008 £0
Julie Brown 44,444 £0
Anne Beal 7,780 £0
Harry (Hal) C. Dietz 6,206 £0
Elizabeth (Liz) McKee Anderson 4,679 £0
Wendy Becker 3,503 £0
Jeannie Lee 3,298 £0
Luke Miels 3 £0

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £0
Dodge & Cox 253,464,108 £0
BlackRock Inc 231,975,400 £0
GSK plc 197,068,169 £0
The Capital Group Companies, Inc. 159,068,073 £0
Legal & General Group Plc 95,878,187 £0

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,881.00p
Closing Price Change 23.00p
% Change 0.00 %
52 Week High 1,901.50
52 Week Low 1,264.00
Volume 0
Shares Issued 4,075.43m
Beta 0.94
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for 15-Jan-2026

Time Volume / Share Price
15:08 161 @ 1,861.75p
15:08 310 @ 1,862.00p
15:08 116 @ 1,861.50p
15:08 134 @ 1,861.50p
15:08 10 @ 1,861.50p

GSK Key Personnel

CEO Luke Miels

Top of Page